Xromi Solution
NDC Package 62484-0015-5
Package Information
Xromi (hydroxyurea) solution is xROMI is indicated to reduce the frequency of painful crises and reduce the need for blood transfusions in pediatric patients aged 6 months of age and older with sickle cell anemia with recurrent moderate to severe painful crises. This formulation utilizes a solution delivery system. Marketed by Nova Laboratories, Ltd., this product is identified by NDC 62484-0015 and is authorized under FDA application NDA216593.
Identification & Billing
- RxCUI: 2682741 - hydroxyurea 100 MG in 1 mL Oral Solution
- RxCUI: 2682741 - hydroxyurea 100 MG/ML Oral Solution
- RxCUI: 2682741 - hydroxyurea 100 MG per 1 mL Oral Solution
- RxCUI: 2696079 - Xromi 100 MG in 1 mL Oral Solution
- RxCUI: 2696079 - hydroxyurea 100 MG/ML Oral Solution [Xromi]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62484 - Nova Laboratories, Ltd.
- 62484-0015 - Xromi
- 62484-0015-5 - 1 BOTTLE in 1 CARTON / 148 mL in 1 BOTTLE (62484-0015-4)
- 62484-0015 - Xromi
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62484-0015-5 identifies a specific commercial package of 1 bottle in 1 carton / 148 ml in 1 bottle (62484-0015-4) of Xromi, a human prescription drug labeled by Nova Laboratories, Ltd.. This solution is formulated for oral use and contains hydroxyurea as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nova Laboratories, Ltd. on April 04, 2024. The current certification is valid through December 31, 2027.
How is this Nova Laboratories, Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62484001505. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 148 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.